NCT00651365View on ClinicalTrials.gov

A Safety and Dose-finding Study of JNJ-38877605 in Patients With Advanced or Refractory Solid Tumors.

PHASE1TerminatedINTERVENTIONAL

Enrollment

14

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions

Neoplasms

Interventions

DRUG

JNJ-38877605

Sponsors

Collaborators (1)

Ortho Biotech, Inc.

All Listed Sponsors

collaborator

Ortho Biotech, Inc.

INDUSTRY

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY